Medical Health Cluster


A Possible Biomarker for COVID-19 Cognitive Impairment

The study covered in this summary was published on as a preprint and has not yet been peer reviewed. Key Takeaways This study demonstrated that participants with previous SARS-CoV-2 infections had mild to moderate cognitive impairment up to 4 months after diagnosis, independently of baseline cognitive function. Mild cognitive decline is […]

Read More